DRW Securities’s Hims & Hers Health HIMS Stock Holding History

DRW Securities’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.26M	Buy	+122,900	New	+$3.3M	0.1%	130

Other funds holding HIMS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

DRW Securities's HIMS Position: Q2 2025 in Review

DRW Securities sold out of Hims & Hers Health (HIMS) in Q2 2025, closing a stake of 17,343 shares — an estimated $512K sold.

DRW Securities first reported a position in HIMS in Q1 2024 and held it in 4 quarters. The position peaked at $2.02M in Q3 2024. 510 funds tracked by Wall St. Rank hold HIMS as of Q2 2025.

DRW Securities reported no remaining Hims & Hers Health position as of Q2 2025 after selling out during the quarter.
DRW Securities sold 17,343 Hims & Hers Health shares in Q2 2025, an estimated $512K.
DRW Securities first reported a position in Hims & Hers Health in Q1 2024 and held it in 4 quarters.
DRW Securities's Hims & Hers Health position peaked at $2.02M in Q3 2024.
510 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2025.

Based on DRW Securities's 13F filing for Q2 2025, filed 14 Aug 2025.